FTSE All-Share
|
5 267,14
|
33,32
|
0,64 %
|
Analysen zu FTSE All-Share-Werten
| 16.01.24 | Rio Tinto Neutral | UBS AG | |
| 16.01.24 | AstraZeneca Sell | UBS AG | |
| 15.01.24 | GSK Buy | UBS AG | |
| 15.01.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 15.01.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 15.01.24 | Unilever Sell | UBS AG | |
| 15.01.24 | National Grid Buy | Deutsche Bank AG | |
| 15.01.24 | Vodafone Group Neutral | JP Morgan Chase & Co. | |
| 12.01.24 | Vodafone Group Equal Weight | Barclays Capital | |
| 12.01.24 | Glencore Equal Weight | Barclays Capital | |
| 12.01.24 | Rio Tinto Overweight | Barclays Capital | |
| 12.01.24 | Glencore Buy | Goldman Sachs Group Inc. | |
| 12.01.24 | Rio Tinto Buy | Goldman Sachs Group Inc. | |
| 11.01.24 | Glencore Buy | Deutsche Bank AG | |
| 11.01.24 | Rio Tinto Buy | Deutsche Bank AG | |
| 10.01.24 | Diageo Underperform | RBC Capital Markets | |
| 10.01.24 | BAT Neutral | JP Morgan Chase & Co. | |
| 10.01.24 | Unilever Underweight | JP Morgan Chase & Co. | |
| 10.01.24 | GSK Buy | Deutsche Bank AG | |
| 10.01.24 | Diageo Neutral | JP Morgan Chase & Co. | |
| 09.01.24 | GSK Equal Weight | Barclays Capital | |
| 09.01.24 | GSK Equal Weight | Barclays Capital | |
| 09.01.24 | GSK Sell | UBS AG | |
| 09.01.24 | Rio Tinto Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.01.24 | Shell Overweight | JP Morgan Chase & Co. | |
| 08.01.24 | Diageo Outperform | Bernstein Research | |
| 08.01.24 | Shell Outperform | RBC Capital Markets | |
| 08.01.24 | Rio Tinto Neutral | UBS AG | |
| 08.01.24 | Shell Buy | Jefferies & Company Inc. | |
| 08.01.24 | Shell Overweight | Barclays Capital | |
| 08.01.24 | Shell Buy | UBS AG | |
| 08.01.24 | HSBC Holdings Buy | Jefferies & Company Inc. | |
| 05.01.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 05.01.24 | AstraZeneca Hold | Deutsche Bank AG | |
| 04.01.24 | BP Overweight | Barclays Capital | |
| 04.01.24 | Shell Overweight | Barclays Capital | |
| 04.01.24 | BP Outperform | RBC Capital Markets | |
| 04.01.24 | Shell Outperform | RBC Capital Markets | |
| 03.01.24 | Unilever Underweight | JP Morgan Chase & Co. | |
| 03.01.24 | AstraZeneca Overweight | Barclays Capital |
HOT STOCKS DER LETZTEN 3 TAGE
| BP | 5 |
| GSK | 2 |
| Unilever | 1 |
| London Stock Exchange | 1 |
| Rio Tinto | 1 |
| HSBC Holdings | 1 |
| Shell | 1 |
| Diageo | 1 |
| Vodafone Group | 1 |
Analysen zu Aktien folgender Indizes
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.